slides · global inventory
Analyze Data
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 58,039
Current window 26,431-26,460
Pages 1,935
Rows per page 30
Slide function
26,431-26,460 of 58,039
10
Includes percentage change column.Hypebeast | Results Presentation Deck | 12 slides · Hypebeast
Conference presentation Investor relations 1 hit
04
Data sourced from Bain/Altagamma, November 2021.Kering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations Beat · Setup1 hit
10
Includes footnotes regarding IFRS 5 restatement and 2019 tax settlement adjustments.Kering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations Beat · Complication1 hit
13
The slide uses a hub-and-spoke diagram to illustrate the ownership structure of Kering.Kering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations Beat · Problem & Complication1 hit
15
The 2021 column is highlighted with a box to emphasize current status.Kering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations Beat · Problem & Complication1 hit
16
Kering | ESG Presentation Deck | 79 slidesKering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations Beat · Problem & Complication1 hit
21
The slide uses a 2x2-style risk matrix (Impact vs Probability) to categorize risks into different quadrants.Kering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations Beat · WhatLoop · Golden Circle1 hit
23
Kering | ESG Presentation Deck | 79 slidesKering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations Beat · WhatLoop · Golden Circle1 hit
24
Includes a footnote explaining the 2020 COVID-19 related adjustments.Kering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations Beat · WhatLoop · Golden Circle1 hit
25
The slide uses a stacked bar chart to represent the 70/30 split between financial and non-financial targets, linked to detailed payout tables.Kering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations Beat · WhatLoop · Golden Circle1 hit
26
The chart illustrates a piecewise linear function for bonus payout based on performance percentage.Kering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations Beat · WhatLoop · Golden Circle1 hit
29
The slide highlights a shift towards ESG targets and adjusted financial criteria for executive compensation.Kering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations Beat · WhatLoop · Golden Circle1 hit
30
Includes detailed footnotes explaining the remuneration logic and specific roles like the Lead Independent Director.Kering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations Beat · WhatLoop · Golden Circle1 hit
40
The slide uses a bubble matrix to visualize impact distribution and a dual-axis line chart to show decoupling of revenue from environmental impact.Kering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations Beat · New Bliss1 hit
44
The slide uses pie charts on a map to represent environmental impact categories (Air Emissions, GHGs, Land Use, Waste, Water Consumption, Water Pollution) by region.Kering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations 1 hit
78
The slide outlines the specific financial and operational constraints for the company's share buyback program.Kering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations 1 hit
22
Data shows significant upregulation of IRAK4 in lesional skin compared to healthy controls across multiple cell types and measurement methods.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
23
Data source: Alavi et al., Society for Investigative Dermatology Annual Meeting, 2021.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
24
The left chart is a volcano plot showing selectivity; the right chart is a dose-response curve comparing the degrader to a kinase inhibitor.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
25
Includes bar charts for degradation and physiological markers, plus a line chart for EAE clinical scores.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
27
SAD = Single Ascending Dose; MAD = Multiple Ascending Dose.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
28
The chart displays mean (± SE) percent IRAK4 change from baseline. P-values are relative to placebo.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
30
Data shows mean percentage change from baseline for various cytokines (IFNy, IL1b, IL6, IL8, IL10, IL12, IL17, TNFa).Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
33
The slide compares Day 1 and Day 14 PK profiles, highlighting the accumulation and steady-state achievement.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
34
Data beyond day 14 is noted as pending.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
35
Data shows high efficacy at lower doses with a plateau effect observed at 100mg.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
36
The slide compares IRAK4 reduction percentages across two cell types (lymphocytes and monocytes) at Day 7 and Day 14 for various dosage groups.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
37
Data shows significantly higher accumulation in skin tissue compared to plasma at trough levels.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
38
Data presented at Kymera R&D Day 2021. LLOQ = Lower Limit of Quantitation.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
40
Data shows dose-dependent reduction in cytokine levels compared to placebo, correlated with IRAK4 degradation percentages.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit